
Heart Attack Symptoms, Causes, and Treatment
A heart attack is a stoppage of blood flow to the heart. While chest pain is the most common symptom, recognizing other symptoms can help ensure you receive prompt treatment and limit damage to your heart.
Heart attacks are very common in the United States. About 805,000 heart attacks occur each year, or roughly one every 40 seconds.
Chest pain is the most common warning sign of a heart attack. But other symptoms can also occur, like lightheadedness, nausea, and shortness of breath.
Symptoms can be severe or mild and often vary from one person to the next. Some people may not even notice any warning signs of a heart attack.
This article will take a closer look what causes a heart attack, how to recognize it, what steps to take, and what to expect for treatment.
What is a heart attack?
A heart attack, also known as a myocardial infarction, occurs when blood flow to the heart is blocked or cut off. If there's not enough oxygen-rich blood flowing to the heart, it can damage the affected area. As a result, the heart muscle begins to die.
When your heart isn't getting the blood and oxygen it needs to function properly, it can put you at a higher risk of heart failure and other serious complications.
A heart attack is a life threatening medical emergency
If you, or someone around you, experiences the symptoms of a heart attack, call 911 or your local emergency services immediately. The sooner you can get medical treatment that restores normal blood flow to your heart, the better your chance of a successful outcome.
What are the symptoms of a heart attack?
General symptoms for a heart attack can include:
chest pain or discomfort
shortness of breath
pain in your arm, shoulder, or neck
nausea
sweating
lightheadedness or dizziness
fatigue
upper body pain
trouble breathing
Anyone experiencing any of the above heart attack symptoms should contact emergency services immediately.
How heart attack symptoms vary between men and women
Many people experience a mix of heart attack symptoms regardless of sex or gender. However, there are sex-specific differences in the presentation, biology, and outcomes of heart attacks.
A 2019 study found that chest pain was the most common symptom regardless of sex. According to the American Heart Association (AHA), females are somewhat more likely than men to experience the following heart attack symptoms:
shortness of breath
nausea or vomiting
pain in the upper back or jaw
dizziness or lightheadedness
extreme fatigue
How heart attack symptoms may differ for people with diabetes
People with diabetes are more likely to have silent heart attacks compared to people who don't have diabetes. A silent heart attack means you don't experience symptoms, but there's still damage to your heart.
This may be due to cardiac autonomic neuropathy, a type of nerve damage that's a common complication of diabetes. It may interfere with the ability to feel chest pain caused by a heart attack.
Angina vs. heart attack
Angina is chest pain caused by reduced blood flow to the heart. It's the pain you feel during a heart attack, but it's also a symptom of heart disease due to blockages in the arteries that supply blood to your heart.
Some people experience frequent and predictable bouts of angina with triggers like exertion. Known as chronic stable angina, this usually eases with rest within about 5 minutes.
However, angina that's new or changed may be due to a heart attack. If your chest pain doesn't subside with rest or lasts longer than usual, you may be having a heart attack.
What causes a heart attack?
The leading cause of heart attacks is coronary heart disease. That's when plaque builds up in the arteries that supply blood to the heart. The general buildup of plaque in the arteries is also known as atherosclerosis.
Doctors can classify heart attacks according to the cause:
Type 1: The heart attack occurs when a sudden disruption of blood flow occurs due to plaque rupture or a blood clot.
Type 2: The lack of oxygen supply to the heart is not due to an event but a systemic issue, like low blood pressure or a fast heart rate.
Other causes of heart attacks include:
torn blood vessels
blood vessel spasms
drug misuse
hypoxia (lack of oxygen to tissue) or hypoxemia (lack of blood oxygen)
What are the risk factors for a heart attack?
Several factors can put you at greater risk of a heart attack. You can't change some factors, such as age and family history.
However, you can make changes related to the following modifiable risk factors:
smoking
high cholesterol
obesity
lack of exercise
high levels of stress
diabetes or prediabetes
eating a diet high in trans fats and saturated fats
excessive alcohol consumption
sleep apnea
Heart disease is the leading cause of death among most ethnic and racial groups in the United States and the most common cause of heart attacks.
People of any age or sex can have a heart attack. However, your risk of a heart attack increases with age. Older adults are most likely to have heart attacks. Males are more likely to have heart attacks earlier in life. Heart disease risk increases in females after menopause.
You may be at higher risk of a heart attack if you have a family history of any of the following:
heart disease
high blood pressure
high cholesterol
obesity
diabetes
How do doctors diagnose a heart attack?
Doctors typically diagnose a heart attack after they perform a physical exam and review your medical history. A doctor will likely conduct an electrocardiogram (ECG) to check your heart's electrical activity.
Your healthcare team will likely also take a blood sample or perform other tests to check for evidence of heart muscle damage. One common test checks for levels of troponin T, a protein found in the heart muscle. Elevated troponin T levels may suggest a heart attack.
Diagnostic imaging can help doctors see how blood is flowing through the heart and detect if any parts have been damaged. Cardiac catheterization is a test that allows a doctor to visualize blood flow and treat blockages. A doctor may also perform other imaging tests to evaluate the heart, including:
What is the treatment for a heart attack?
If you've had a heart attack, a doctor may recommend a surgical or nonsurgical procedure. These procedures can relieve pain and help prevent another heart attack from occurring.
Common procedures include:
Angioplasty: An angioplasty opens the blocked artery by using a balloon or removing the plaque buildup. Healthcare professionals rarely use angioplasty alone anymore.
Stent: A stent is a wire mesh tube surgeons insert into the artery to keep it open after angioplasty.
Heart bypass surgery: In bypass surgery, a doctor reroutes the blood around the blockage.
Heart transplant: Surgeons may recommend a heart transplant in cases of serious and irreversible heart failure.
A doctor may also prescribe medications to treat your heart attack, including:
aspirin
other drugs to break up clots
antiplatelet and anticoagulants, also known as blood thinners
pain relievers
nitroglycerin
blood pressure medication
beta-blockers
cholesterol-lowering medication like statins
Timing is crucial
Timely treatment of a heart attack is crucial. The sooner you get treatment after having a heart attack, the more quickly blood flow can be restored to the affected part of your heart, and the more successful the outcome is likely to be.
Doctors who treat heart attacks
Since heart attacks are often unexpected, an emergency room doctor is usually the first healthcare professional to diagnose a heart attack. They may also provide initial medications to break up the blood clot.
The emergency doctor will transfer you to a cardiologist, a doctor who specializes in treating heart conditions. Cardiologists perform procedures to treat heart attacks and oversee their management and recovery.
How to help someone having a heart attack
If you are with someone who's experiencing symptoms of a heart attack, call emergency services immediately and follow the instructions they give you regarding what to do.
If the person isn't responsive and doesn't have a pulse, doing cardiopulmonary resuscitation (CPR) or using an automated external defibrillator (AED) can be lifesaving.
Most businesses and many public places have AEDs, but if one isn't present, continue to perform CPR until help arrives. Giving CPR can help pump oxygenated blood through a person's body until emergency services arrive.
The sooner a person can get emergency medical attention, the less damage their heart muscle will likely sustain.
What should you do if you have a heart attack?
If you suspect you're having a heart attack, the AHA advises calling 911 or your local emergency services immediately, rather than attempting to drive yourself to the hospital.
Paramedics can begin treating you when they arrive and monitor you on the way to the emergency department.
Follow the instructions of the emergency personnel on whether to take an aspirin and let them know if you have any medication allergies or bleeding. The antiplatelet qualities of aspirin may help break up the clot that might be blocking blood flow to your heart.
If possible, ask a family member, friend, or neighbor to be with you while you wait for the ambulance or are undergoing treatment at the hospital.
Timely treatment for women who have heart attacks
Because females are more likely to experience atypical heart attack symptoms, they tend to wait longer to contact emergency services, according to a 2019 Swiss study. Researchers also found that women tend to experience greater delays in receiving treatment in emergency settings.
Recognizing the symptoms of heart attacks in females can make a big difference in getting timely treatment.
What are the possible complications of a heart attack?
Heart attacks can result in various complications. When a heart attack occurs, it can disrupt your heart's normal rhythm, potentially stopping it altogether. These abnormal rhythms are known as arrhythmias and can cause sudden cardiac death.
When your heart stops getting a supply of blood during a heart attack, some of the heart tissue can die. This can weaken your heart and cause serious complications such as heart failure.
Heart attacks can also affect your heart valves and cause leaks.
The long-term effects on your heart will depend on how long it takes to receive medical treatment and how much damage your heart sustains.
What to expect during recovery after a heart attack
A heart attack can damage your heart muscles and affect their function. This can include changing your heart's rhythm and reducing its ability to pump blood effectively to all the organs and tissues in your body.
Following a heart attack, it's essential to work with your healthcare team to design a recovery plan. This plan may include the following lifestyle changes:
participating in light or moderate exercise, according to what your doctor approves
eating a nutrient-dense, balanced diet low in saturated and trans fats
losing weight if you're carrying extra weight
quitting smoking if you smoke
monitoring your blood sugar levels closely if you have diabetes
taking steps to keep your blood pressure and cholesterol within a healthy range
avoiding strenuous activities, especially shortly after the heart attack
undergoing cardiac rehabilitation
How to prevent a heart attack
While some risk factors are beyond your control, you can take some basic steps to help keep your heart healthy. Examples include:
Eat a healthy, balanced diet: Try to incorporate heart-healthy foods, like lean proteins, whole grains, fruits, vegetables, and low fat dairy, as often as possible. Limit fatty, fried foods and foods that contain simple sugars like sodas, baked goods, and white bread.
Exercise regularly: Aim for at least 150 minutes of physical activity a week for optimum heart health.
Quit smoking: If you smoke, consider talking with a doctor about starting a smoking cessation program.
Limit your alcohol intake: Moderation is key when it comes to alcohol and heart health. If you do drink, limit yourself to one drink per day for women or two drinks per day for men.
Get your cholesterol levels checked: If your LDL cholesterol or triglycerides are higher than they should be, talk with a doctor about what you need to do to lower them.
Manage diabetes: If you have diabetes, take your medications as prescribed and check your blood glucose levels regularly.
Work with a doctor: If you have a heart condition, work closely with a doctor and follow your treatment plan, which includes taking your medications.
The bottom line
Most people who have a heart attack survive. Still, it's important to know how to reduce your risk and how to respond if you experience symptoms of a heart attack.
While chest pain is the most common symptom, it's only one of several common signs of a heart attack. If you think you may be having a heart attack, call for emergency medical help immediately. The sooner you get treatment for a heart attack, the better the outcome will likely be.
Doctors can use various tests to diagnose a heart attack and guide treatment. Effective treatment plans help restore blood flow and minimize complications.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Deadline for spring COVID-19 booster approaching - who can get it
The NHS in West Yorkshire has encouraged eligible individuals to get a COVID-19 booster before the current vaccination campaign ends on Tuesday, June 17. The booster is being offered to people aged 75 and over, residents in care homes for older adults, and anyone aged six months and over with a weakened immune system. A spokesperson said: "This includes people who have or are receiving treatment for conditions such as diabetes, blood cancer, organ transplant, HIV, or those taking medicines that weaken the immune system, such as high-dose steroids or immunosuppressants following cancer treatment." Dr James Thomas, medical director for the West Yorkshire Integrated Care Board and a Leeds-based GP, said: "Vaccination remains the best way to protect yourself and those around you from the serious effects of COVID-19. "The virus hasn't gone away, and those most at risk can still become seriously unwell. "If you're eligible for the spring booster, please don't miss this opportunity – book now or visit a walk-in pharmacy before June 17." Appointments can be booked through the NHS App, online at or by calling 119. Some walk-in pharmacies are also available across West Yorkshire. A full definition of immunosuppression can be found in Chapter 14a (table 3) of the Green Book:


Health Line
36 minutes ago
- Health Line
Ask the Expert: Should I have Biomarker Testing – and Would it Help?
Biomarker testing in colorectal cancer can help assess inherited risk and identify characteristics that may influence the disease's growth, spread, and response to treatment. Colorectal cancer (CRC) starts in the colon or rectum of the large intestine. Your doctor may refer to it as 'colon cancer' or 'rectal cancer,' depending on where the cancer develops first, but both of these diagnoses are included under the banner of CRC. CRC is treatable, and biomarker testing is a part of precision medicine in your comprehensive treatment plan. Biomarker testing in CRC can help detect cancer in its earliest, most treatable stages. It can also provide important details about cancer after a diagnosis that influence treatment and outcomes. Dr. Smitha Krishnamurthi, a gastrointestinal oncology specialist with the Cleveland Clinic, talks with Healthline about biomarker testing and who it's recommended for. What is biomarker testing? Biomarker testing refers to testing of the colorectal cancer to find out if there are certain changes in the cancer's genes and proteins that could impact prognosis [outlook] and treatment. What are the most common biomarkers, and what do they show? Biomarkers in CRC measure a variety of different biological processes and states. Each biomarker provides important details about the cancer's growth, spread, or treatment response. DNA mismatch repair Hospital pathology labs now commonly test all initial biopsies or surgical specimens of colorectal cancer for the presence of DNA mismatch repair proteins. This is done via immunohistochemistry (IHC) staining of the slides to look for [the] expression of four mismatch repair proteins: MLH1, PMS2, MSH2, and MSH6. If one or two of these proteins are missing, then the cancer has deficient DNA mismatch repair. Microsatellite instability (MSI) This is a polymerase chain reaction (PCR) or next-generation sequencing (NGS) test [that looks] for abnormalities in microsatellite regions of the cancer DNA. The test can be done on a tumor specimen or blood (liquid biopsy). Microsatellites are short, repeated sequences of DNA. If the cancer has [atypical] DNA mismatch repair, errors will appear in microsatellite regions of DNA in the form of missing bases or extra bases added to the DNA sequence. RAS gene mutations (mutations in KRAS and NRAS genes) This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). RAS is a very important oncogene, meaning that it is a gene that, when mutated, drives cancer cell proliferation and survival. Mutations in RAS genes are found in up to 50% of colorectal cancers. BRAF V600E gene mutation This testing can be performed by PCR or NGS testing of the tumor or NGS testing of blood (liquid biopsy). The BRAF V600E protein can also be detected by IHC. BRAF is another oncogene, so when it is mutated, it leads to cancer cell proliferation and survival. BRAF V600E mutations occur in about 8% to 10% of colorectal cancers and are more common in right-sided cancers. HER2 protein overexpression by IHC or gene amplification by NGS HER2 is another oncogene — gene amplification leads to [the] overexpression of the HER2 protein. Overexpression of HER2 leads to increased signaling via the epidermal growth factor receptor pathway, leading to cancer cell proliferation and survival. PIK3CA PIK3CA is another oncogene. Mutations in PIK3CA and a related gene, PIK3R1, lead to cancer cell proliferation and survival. Mutations in PIK3CA and PIK3R1 are typically found via NGS. PTEN PTEN is a tumor suppressor gene, [which typically] suppresses cancer growth. When the PTEN gene is mutated, the protein is not expressed, and that leads to [the] proliferation of cancer. PTEN gene mutations are typically found via NGS. Who should have biomarker testing done? All patients with colorectal cancer should have testing of their cancer for DNA mismatch repair (or microsatellite instability) soon after diagnosis. This is important for patients with cancers of all stages. Patients with early stage colorectal cancer should have testing of their cancers for mutations in PIK3CA, PTEN, and PIK3R1 by the time they finish adjuvant treatment or after surgery if [they're] not having adjuvant treatment. Patients with metastatic colorectal cancer should have next-generation sequencing of the cancer soon after diagnosis, as the results may impact the initial systemic treatment. The NGS results are also useful for identifying clinical trial eligibility. Comorbidities will not affect the results of these biomarkers, so they should not affect the timing and decision making about ordering these tests. How does biomarker testing help the treatment and outcome of a diagnosis? Biomarkers can impact your treatment choices and outcomes. They can help doctors decide which medications will be the most effective, identify inherited features in cancer, and determine if adjuvant or additional therapies would improve outcomes. Immunotherapy responsiveness It is critical to know if a cancer has deficient DNA mismatch repair (dMMR) or high microsatellite instability (MSI-H) because these cancers can respond dramatically to immunotherapy in the early stage and metastatic settings. For example, patients with rectal cancer that is dMMR or MSI-H may have a complete clinical response with immunotherapy and may be able to avoid radiation and surgery. Thus, this testing needs to be done early, before treatment starts. Identifying Lynch syndrome Another important reason for testing for dMMR or MSI-H is to identify cancers caused by Lynch syndrome. Lynch syndrome is the most common type of inherited colorectal cancer and is caused by germline mutations in the genes that code for the DNA mismatch repair proteins or in another related gene called EPCAM. Most cancers with deficient mismatch repair or MSI-H are not caused by Lynch syndrome and occur sporadically. We don't want to miss patients with Lynch syndrome, however, because they can benefit from counseling about [the] prevention of Lynch syndrome-related cancers such as uterine cancer, ovarian cancer, and gastric cancer, in addition to colorectal cancer. When a patient is diagnosed with Lynch syndrome, family members can then be tested to see if they have Lynch syndrome. Recommendations for cancer screening at early stages are made for individuals with Lynch syndrome, and early screening can be lifesaving. Identifying treatment resistance Mutations in KRAS and NRAS make cancers resistant to anti-epidermal growth factor receptor therapy. Cancers with KRAS G12C mutations can be treated with a regimen that targets this mutation (adagrasib plus cetuximab or sotorasib plus panitumumab). There are also many clinical trials now studying RAS gene inhibitors in patients with metastatic colorectal cancer that have been previously treated. Cancers with BRAF V600E tend to be aggressive and less sensitive to chemotherapy. There is a Food and Drug Administration (FDA)-approved regimen targeting BRAF V600E (encorafenib plus cetuximab) in metastatic colorectal cancer that improves survival when added to first-line FOLFOX chemotherapy. It also improves survival as a second-line treatment after chemotherapy. Greater response to targeted and adjuvant therapy Metastatic colorectal cancers that demonstrate [the] overexpression or gene amplification of HER2 can be treated with a targeted regimen of tucatinib plus trastuzumab after initial chemotherapy. Another targeted treatment available for metastatic colorectal cancers that overexpress HER2 by IHC is trastuzumab deruxtecan. Patients with early stage colorectal cancer with mutations in the PIK3CA, PIK3R1, or PTEN genes should be treated with aspirin 160 milligrams daily for 3 years after adjuvant therapy or after surgery if [they're] not having adjuvant therapy. The ALASCCA trial, presented at ASCO GI [American Society of Clinical Oncology – Gastrointestinal Cancer] in 2025, compared a placebo to aspirin in this patient population and found that aspirin significantly lowered the rate of cancer recurrence at 3 years. This is rather new data. Oncologists are starting to order NGS testing for patients with early stage cancers in order to obtain this biomarker information. What should you ask your doctor? It's always OK to ask your doctor about biomarker testing and what it means for you. Important questions to consider include: Is my cancer dMMR/MSI-H? Am I a candidate for immunotherapy? Patients with early stage colorectal cancer should ask if aspirin therapy will be recommended based on biomarker testing. Patients with metastatic colorectal cancer should ask for the results of RAS/BRAF/HER2 testing and overall NGS testing results.
Yahoo
40 minutes ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data